Cargando…

Ketoacidosis with euglycemia in a patient with type 2 diabetes mellitus taking dapagliflozin: A case report

RATIONALE: Dapagliflozin (a sodium-glucose cotransporter-2 [SGLT2] inhibitor) represents the most recently approved class of oral medications for the treatment of type 2 diabetes. Dapagliflozin lowers plasma glucose concentration by inhibiting the renal reuptake of glucose in the proximal renal tubu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yeo, Sang Mok, Park, Hayeon, Paek, Jin Hyuk, Park, Woo Yeong, Han, Seungyeup, Park, Sung Bae, Jin, Kyubok
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370067/ https://www.ncbi.nlm.nih.gov/pubmed/30653152 http://dx.doi.org/10.1097/MD.0000000000014150

Ejemplares similares

Effectiveness of valacyclovir prophylaxis against the occurrence of cytomegalovirus infection in kidney transplant recipients
por: Park, Woo Yeong, et al.
Publicado: (2020)

Clinical significance of serum galactose-deficient immunoglobulin A1 for detection of recurrent immunoglobulin A nephropathy in kidney transplant recipients
por: Park, Woo Yeong, et al.
Publicado: (2021)

Clinical significance of de novo donor-specific antibody in kidney transplant recipients with chronic antibody-mediated rejection
por: Park, Woo Yeong, et al.
Publicado: (2021)

Clinical characteristics and risk factors for kidney failure in patients with autosomal dominant polycystic kidney disease: A retrospective study
por: Park, Hanil, et al.
Publicado: (2022)

Impact of calcineurin inhibitors on rat glioma cells viability
por: Seong, Jeong Hun, et al.
Publicado: (2019)

Chaga mushroom-induced oxalate nephropathy that clinically manifested as nephrotic syndrome: A case report
por: Kwon, Ohyun, et al.
Publicado: (2022)

Long-term prognosis of BK virus-associated nephropathy in kidney transplant recipients
por: Park, Woo Yeong, et al.
Publicado: (2018)

Genetic variants of interferon lambda-related genes and chronic kidney disease susceptibility in the Korean population
por: Kwak, Jin Ho, et al.
Publicado: (2022)

Severe acute kidney injury in COVID-19 patients is associated with in-hospital mortality
por: Paek, Jin Hyuk, et al.
Publicado: (2020)

A Pedigree with c.179 Cytosine to Threonine Missense Mutation of SLC12A3 Gene Presenting Gitelman's Syndrome
por: Kim, Yaerim, et al.
Publicado: (2016)

Dapagliflozin-induced Late-onset Euglycemic Diabetic Ketoacidosis
por: Iqbal, Iqra, et al.
Publicado: (2019)

Impact of albuminuria on the various causes of death in diabetic patients: a nationwide population-based study
por: Cho, Semin, et al.
Publicado: (2023)

Postoperative Ketoacidosis With Hypoglycemia in a Nondiabetic Patient Taking Dapagliflozin for Heart Failure: A Case Report
por: Seki, Hiroyuki, et al.
Publicado: (2022)

Euglycemic diabetic ketoacidosis caused by dapagliflozin: A case report
por: Chou, Yu-Mou, et al.
Publicado: (2018)

Impact of acute kidney injury in deceased donors with high Kidney Donor Profile Index on posttransplant clinical outcomes: a multicenter cohort study
por: Park, Woo Yeong, et al.
Publicado: (2021)

The comparative efficacy and safety of basiliximab and antithymocyte globulin in deceased donor kidney transplantation: a multicenter cohort study
por: Hong, Su Yeon, et al.
Publicado: (2023)

Dapagliflozin-associated euglycemic diabetic ketoacidosis in a patient with type 2 diabetes mellitus: A case report
por: Lee, In Hee, et al.
Publicado: (2020)

Prolonged Ketosis in a Patient With Euglycemic Diabetic Ketoacidosis Secondary to Dapagliflozin
por: Pujara, Shreya, et al.
Publicado: (2017)

Euglycemic Diabetic Ketoacidosis Secondary to Dapagliflozin in a Patient with Colon Malignancy
por: Papadokostaki, Eleni, et al.
Publicado: (2019)

G(q) signaling in α cells is critical for maintaining euglycemia
por: Liu, Liu, et al.
Publicado: (2021)

Euglycemic diabetic ketoacidosis in association with dapagliflozin use after gastric sleeve surgery in a patient with type II diabetes mellitus
por: Banakh, Iouri, et al.
Publicado: (2019)

Dapagliflozin-Associated Euglycemic Diabetic Ketoacidosis in a Patient Presenting with Acute Pancreatitis
por: Badwal, Karun, et al.
Publicado: (2018)

Therapeutic role of hyperinsulinemia/euglycemia in aluminum phosphide poisoning
por: Hassanian-Moghaddam, Hossein, et al.
Publicado: (2016)

Changing pattern and safety of pretransplant malignancy in kidney transplant recipients
por: Ban, Tae Hyun, et al.
Publicado: (2019)

Plasma heat shock protein response to euglycemia in type 2 diabetes
por: Atkin, Alexander S, et al.
Publicado: (2021)

Impact of decreased levels of total CO2 on in-hospital mortality in patients with COVID-19
por: Kim, Yaerim, et al.
Publicado: (2023)

The minimum-mortality estimated glomerular filtration rate percentile shifts upward in the aged population: a nationwide population-based study
por: Kim, Yaerim, et al.
Publicado: (2020)

Clinical efficacy of biomarkers for evaluation of volume status in dialysis patients
por: Park, Woo Yeong, et al.
Publicado: (2020)

Diabetic ketoacidosis inducing myocardial infarction secondary to treatment with dapagliflozin: a case report
por: Gil‐Perdomo, José M., et al.
Publicado: (2017)

Normoglycemic diabetic ketoacidosis in a type 2 diabetes patient on dapagliflozin: A case report
por: Matli, Venkata Vinod Kumar, et al.
Publicado: (2021)

Clinical significance of the Kidney Donor Profile Index in deceased donors for prediction of post-transplant clinical outcomes: A multicenter cohort study
por: Lee, Jong Hoon, et al.
Publicado: (2018)

Impact of acute kidney injury in expanded criteria deceased donors on post-transplant clinical outcomes: multicenter cohort study
por: Park, Woo Yeong, et al.
Publicado: (2019)

Severe, New-Onset Diabetes Mellitus Triggered by COVID-19 Infection Followed by Euglycemia Upon Recovery: A Case Report
por: Yu, Ian, et al.
Publicado: (2021)

Comparative cardiovascular outcomes in type 2 diabetes patients taking dapagliflozin versus empagliflozin: a nationwide population-based cohort study
por: Lim, Jaehyun, et al.
Publicado: (2023)

Dapagliflozin-Associated Euglycemic Diabetic Ketoacidosis Presenting With Severe Abdominal Pain Mimicking Acute Peritonitis
por: Wang, Qianwen, et al.
Publicado: (2022)

Elucidating the Mechanisms Behind the Restoration of Euglycemia After Gastric Bypass Surgery
por: Näslund, Erik, et al.
Publicado: (2013)

Euglycemia in Diabetic Rats Leads to Reduced Liver Weight via Increased Autophagy and Apoptosis through Increased AMPK and Caspase-3 and Decreased mTOR Activities
por: Lee, Jun-Ho, et al.
Publicado: (2015)

LBSUN291 Fournier's Gangrene In A Diabetic Male Taking Dapagliflozin
por: Patel, Janki M, et al.
Publicado: (2022)

Effect of Dapagliflozin on Alanine Aminotransferase Improvement in Type 2 Diabetes Mellitus with Non-alcoholic Fatty Liver Disease
por: Choi, Dug-Hyun, et al.
Publicado: (2018)

β-arrestin-1 suppresses myogenic reprogramming of brown fat to maintain euglycemia
por: Pydi, Sai P., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_efr90viarid94ba5a3v7mtdjla